Ticker
PRCT
Analysis
Procept Biorobotics Corporation (PRCT) Stock Analysis
Procept Biorobotics Corporation investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to PRCT.
Procept Biorobotics Corporation
Procept Biorobotics Corporation investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to PRCT.
Stock profile
Asset type
Stock
Market cap
$1.24B
Sector
Health Technology
Industry
Medical Specialties
Currency
USD
Ticker listings
Procept Biorobotics Corporation may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
- PRCT primary listing
Latest Procept Biorobotics Corporation news
PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval
SAN JOSE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) today announced two milestones in its WATER IV prostate cancer clinical program: completion...
PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June
SAN JOSE, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by develop...
PROCEPT BioRobotics Reports First Quarter 2026 Financial Results
SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient ca...
PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026
SAN JOSE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient ca...
Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems
Sonder Capital, a healthcare venture capital firm investing in companies revolutionizing the standard of care, today announced the closing of its second fund, Futures II.
Research sections
Valuation
Review valuation context for Procept Biorobotics Corporation.
Future growth
Review future growth context for Procept Biorobotics Corporation.
Past performance
Review past performance context for Procept Biorobotics Corporation.
Financial health
Review financial health context for Procept Biorobotics Corporation.
Dividend
Review dividend context for Procept Biorobotics Corporation.
Management
Review management context for Procept Biorobotics Corporation.
Ownership
Review ownership context for Procept Biorobotics Corporation.
Other information
Review other information context for Procept Biorobotics Corporation.
Community
Review community context for Procept Biorobotics Corporation.